KIM JULIE SO-YOUNG (CEO - Elect) received a stock award from TAKEDA PHARMACEUTICAL CO LTD
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/28/2026ACC: 0001395064-26-000128
Officer· CEO - Elect
Since Mar 2026
+105.42K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
105.42K acquired
Non-Derivative Transactions1
American Depositary Shares
Direct
Shares
+105.42K
Price / share
—
Trade value
—
% of position
32.5%
4/27/2026
324.73K→430.14K
Total
Net shares
+105.42K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares Direct | 4/27/2026 | A · Award | +105.42K | — | — | 32.5% | 324.73K | 430.14K |
| Total | +105.42K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported